{"celex_id": "31998D0393", "uri": "http://publications.europa.eu/resource/cellar/3b5cd6b2-b6e3-4168-ba4c-8abe95854e3d", "type": "Decision", "concepts": ["3003", "4291", "4635", "5283", "862", "994"], "title": "98/393/EC: Commission Decision of 19 May 1998 on financial assistance from the Community for storage in France, Italy and the United Kingdom of antigen for production of foot-and-mouth disease vaccine (notified under document number C(1998) 1365) (Only the English, French and Italian texts are authentic) (Text with EEA relevance)\n", "header": "COMMISSION DECISION of 19 May 1998 on financial assistance from the Community for storage in France, Italy and the United Kingdom of antigen for production of foot-and-mouth disease vaccine (notified under document number C(1998) 1365) (Only the English, French and Italian texts are authentic) (Text with EEA relevance) (98/393/EC)\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Community,\nHaving regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), as last amended by Decision 94/370/EC (2), and in particular Article 14 thereof,\nWhereas by virtue of Council Decision 91/666/EEC of 11 December 1991 establishing Community reserves of foot-and-mouth disease vaccines (3), establishment of antigen banks is part of the Community's action to create Community reserves of foot-and-mouth disease vaccine;\nWhereas Article 3 of that Decision designates the 'Laboratoire de pathologie bovine du Centre national d'\u00e9tudes v\u00e9t\u00e9rinaires et alimentaires` at Lyon in France, the 'Istituto Zooprofilattico Sperimentale die Brescia` in Italy and the 'Institute for Animal Health` at Pirbright in the United Kingdom as antigen banks holding Community reserves;\nWhereas the functions and duties of these antigen banks are specified in Article 4 of that Decision; whereas Community assistance must be conditional on accomplishment of these;\nWhereas Community financial assistance should be granted to these banks to enable them to carry out during 1998 the said functions and duties;\nWhereas for budgetary reasons the Community assistance should be granted for a period of one year;\nWhereas for supervisory purposes Articles 8 and 9 of Council Regulation (EEC) No 729/70 of 21 April 1970 on financing of the common agricultural policy (4), as last amended by Regulation (EC) No 1287/95 (5), should apply;\nWhereas the measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee,", "main_body": ["1. The Community shall grant France financial assistance for the stocking of antigen for production of foot-and-mouth disease vaccine.\n2. The 'Laboratoire de pathologie bovine du Centre national d'\u00e9tudes v\u00e9t\u00e9rinaires et alimentaires` at Lyon in France shall hold the stock of antigen to which paragraph 1 relates. The provisions of Article 4 of Decision 91/666/EEC shall apply.\n3. The Community's financial assistance shall be a maximum of ECU 40 000 for the period 1 January to 31 December 1998.", "1. The Community shall grant Italy financial assistance for the stocking of antigen for production of foot-and-mouth disease vaccine.\n2. The 'Istituto Zooprofilattico Sperimentale di Brescia` in Italy shall hold the stock of antigen to which paragraph 1 relates. The provisions of Article 4 of Decision 91/666/EEC shall apply.\n3. The Community's financial assistance shall be a maximum of ECU 40 000 for the period 1 January to 31 December 1998.", "1. The Community shall grant the United Kingdom financial assistance for the stocking of antigen for production of foot-and-mouth disease vaccine.\n2. The Institute for Animal Health at Pirbright in the United Kingdom shall hold the stock of antigen to which paragraph 1 relates. The provisions of Article 4 of Decision 91/666/EEC shall apply.\n3. The Community's financial assistance shall be a maximum of ECU 40 000 for the period 1 January to 31 December 1998.", "1. The Community's financial assistance referred to in Article 1(3), Article 2(3) and Article 3(3) shall be paid as follows:\n- 70 % by way of an advance at the request of the Member State concerned,\n- the balance following presentation, by the Member State concerned, of supporting documents which demonstrate the effective completion of the tasks.\n2. The supporting documents referred to in paragraph 1 must be presented to the Commission before 1 March 1999 and they should include:\n(a) technical information on:\n- the amount and type of antigen stored (storage records),\n- storage equipment used (type, number and capacity of tanks),\n- security system in place (temperature control, anti-theft measures),\n- insurance arrangements (fire, accidents);\n(b) financial information (completion of table as shown in the Annex).", "Articles 8 and 9 of Regulation (EEC) No 729/70 shall apply mutatis mutandis.", "This Decision is addressed to the French Republic, the Italian Republic and the United Kingdom of Great Britain and Northern Ireland."], "attachments": "Done at Brussels, 19 May 1998.\nFor the Commission\nFranz FISCHLER\nMember of the Commission\n(1) OJ L 224, 18. 8. 1990, p. 19.\n(2) OJ L 168, 2. 7. 1994, p. 31.\n(3) OJ L 368, 31. 12. 1991, p. 21.\n(4) OJ L 94, 28. 4. 1970, p. 13.\n(5) OJ L 125, 8. 6. 1995, p. 1.\nANNEX\nFinancial information related to the storage of antigen for production of foot-and-mouth disease vaccine\nSTATEMENT OF COSTS\n>START OF GRAPHIC>\nReporting period from\tto\nReference No of Commission Decision providing financial assistance:\nName and address of beneficiary:\t\t\tCategory of costs\tAmount for the period (National currency) (1)\n1. Staff\t2. Capital equipment\t3. Consumables\t4. Insurance\t5. Rental of premises\tTotal\t(1) All costs must be expressed in national currency.\nCertificate by the beneficiary\nWe certify that:\n- the above costs were incurred in connection with the tasks defined in the Decision and were essential to the sound performance of those tasks,\n- they are genuine costs falling within the definition of reimbursable costs,\n- all the documents supporting the costs are available for audit purposes.\nDate:\nName of technical director:\nSignature:\nDate:\nPerson financially responsible:\nSignature:\n>END OF GRAPHIC>"}